AS
Therapeutic Areas
Arcturus Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KOSTAIVE® (ARCT-154) | COVID-19 | Approved |
| LUNAR®-OTC (ARCT-810) | Ornithine Transcarbamylase Deficiency | Phase 2 |
| LUNAR®-CF (ARCT-032) | Cystic Fibrosis | Phase 2 |
| LUNAR®-FLU (ARCT-2304) | Pandemic Influenza (H5N1) | Phase 1 |
| LUNAR®-FLU (ARCT-2138) | Seasonal Influenza | Phase 1 |
Leadership Team at Arcturus Therapeutics
JE
Joseph E. Payne
President, Chief Executive Officer, Co-Founder, Director
PC
Pad Chivukula
Chief Scientific Officer, Chief Operating Officer
SS
Steve Sabo
Chief Executive Officer of ARCALIS
MM
Magda Marquet
Co-Founder, Director
PF
Peter Farrell
Chairman of the Board